Anaplastic large cell lymphoma Archives

source: shutterstock

Rare Classroom: Systemic Anaplastic Large Cell Lymphoma

Post author:James Moore
Post published:January 15, 2021
Post category:Anaplastic large cell lymphoma

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Source: Pixabay

Christmas in the Hospital: Gareth’s Story

Post author:Kendall Mason
Post published:December 18, 2019
Post category:Anaplastic large cell lymphoma Graft versus Host Disease

Gareth Crabb is a thoughtful and caring six-year-old boy from Swansea, U.K. He is spending his second Christmas in the hospital this year, as he has anaplastic large cell…

$The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma$

Source: Pixabay

The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma

Post author:Anna Hewitt
Post published:June 20, 2018
Post category:Anaplastic large cell lymphoma Cancer

The U.S. Food and Drug Administration (FDA) has approved the medicine Keytruda for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma, that have relapsed…

Rare Classroom: Systemic Anaplastic Large Cell Lymphoma

Christmas in the Hospital: Gareth’s Story

The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma

Make a difference, share your experiences and get paid. Opt-in & join Patient Worthy’s panel for paid opportunities such as Surveys, Market Research, Patient Advisory Panels & much more.

Let’s Work Together!

Keep Up to Date

Learn More

SIGN UP FOR OUR NEWSLETTER
Email Address